FDA considers updating blood donation guidelines to keep nation's supply safe from malaria [CNN]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: CNN
The World Health Organization says malaria is a significant global health issue , with 249 million cases and more than 608,000 deaths in 2022 alone. Malaria is not considered a big threat to the US blood supply like it is in some other countries. But nearly 28 million US residents travel to parts of the world where malaria is common each year, the FDA says, and as more Americans travel and as the planet gets warmer, scientists have predicted that the disease could become more likely in the US, even with aggressive mosquito control. As late as the 1940s, the US Centers for Disease Control and Prevention said Thursday in a presentation to the FDA's advisory committee, the US had about 65,000 cases of malaria a year – but that changed when the country needed healthy service members to fight in World War II. Knowing that many would train in malaria-prone areas in the South, President Franklin Delano Roosevelt's government waged a war on mosquitoes that paid off. By 1949, according
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Emerging Leaders: Roche And Viking Therapeutics In The Obesity Treatment Race [Seeking Alpha]Seeking Alpha
- Roche Holding AG (OTCMKTS: RHHBY) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "sell" rating to a "hold" rating.MarketBeat
- Canopy and Flatiron Health Announce Partnership to Streamline Continuous Care Management for OncoEMR® Customers [Yahoo! Finance]Yahoo! Finance
- [Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity [Yahoo! Finance]Ad hoc announcement pursuant to Art. 53 LR
- Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With ObesityBusiness Wire